Preclinical Imaging

by Institute of Bioengineering and Bioimaging(IBB)

Imaging Today the Medicine of Tomorrow

Molecular imaging is an indispensable tool in studying human diseases and drug discovery. Pre-clinical imaging allows longitudinal and translational research for identifying disease pathways, determining mechanism of actions, evaluating drug efficacy, and monitoring their effects on disease progression in living animals. IBB provides state-of-the-art imaging solutions to investigate human diseases using molecular physiology and advanced bioimaging tools and help enhance the efficiency and pace of drug discovery and development.

Scope of Services

IBB provides an augmented fee-for-service capability offering a comprehensive array of standard and bespoke preclinical imaging solutions in oncology, neuroscience , cardiology, metabolic diseases and diagnostic imaging.

As an A*STAR Research Institute, with a multidisciplinary team of investigators and strong ties to the other research institutes, IBB can provide specialised cutting-edge solutions to augment and advance your preclinical research.

Key Capabilities

Imaging Technologies

IBB offers a comprehensive array of dedicated multi-modal preclinical imaging resources unmatched in the commercial space.

Nuclear Imaging:

1. Positron Emission Tomography (PET)

Siemens Inveon PET-CT	Mediso 3T MRI-PET
Mediso Nano SPECT-CT

2. Magnetic Resonance Imaging & Spectroscopy (MRI/MRS)

9.4 Tesla (Bruker Biospec)	Ultra-high field 11.7T Bruker BioSpec
Dynamic Nuclear Polarization (DNP) systems (HyperSense)

Optical Imaging:

Multifunctional fiber optic spectroscopy	Multi-spectral optoacoustic tomography (IBB-iThera Medical)
Multi-modal near infrared spectroscopy (NIRS)-Fluorescence-MRI	Raster scanning optoacoustic mesoscopy
Optoacoustic imaging	Photoacoustic microscopy (IBB-MPA)
Confocal raman microscope